← Open Payments lookup

BERGEN KASSOFF: Open Payments

NPI 1295420875 · WASHINGTON, DC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,308 in 54 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $865 · 2025 $1,308

Food & beverage: $1,308
CompanyPaymentsAmount
Janssen Biotech, Inc.16$348
ABBVIE INC.8$231
Takeda Pharmaceuticals U.S.A., Inc.5$154
Salix Pharmaceuticals, a division of Bausch Health US, LLC4$119
Ardelyx, Inc.5$117
Phathom Pharmaceuticals, Inc.4$67
PFIZER INC.3$66
Intercept Pharmaceuticals, Inc.2$48
Novo Nordisk Inc2$35
Celltrion USA Inc.1$33

Products named: TREMFYA, XIFAXAN, IBSRELA, ENTYVIO, RINVOQ, VOQUEZNA, LINZESS, VIBERZI.

Industry payments across DC — which companies pay providers there.